Syrian hamsters as a small animal model for SARS-CoV-2 infection and countermeasure development.
Masaki Imai,Kiyoko Iwatsuki-Horimoto,Masato Hatta,Samantha Loeber,Peter Halfmann,Noriko Nakajima,Tokiko Watanabe,Michiko Ujie,Kenta Takahashi,Mutsumi Ito,Shinya Yamada,Shufang Fan,Shiho Chiba,Makoto Kuroda,Lizheng Guan,Kosuke Takada,Tammy Armbrust,Aaron Balogh,Yuri Furusawa,Moe Okuda,Hiroshi Ueki,Atsuhiro Yasuhara,Yuko Sakai-Tagawa,Tiago J. S. Lopes,Tiago J. S. Lopes,Maki Kiso,Seiya Yamayoshi,Noriko Kinoshita,Norio Ohmagari,Shin-ichiro Hattori,Makoto Takeda,Hiroaki Mitsuya,Florian Krammer,Tadaki Suzuki,Yoshihiro Kawaoka,Yoshihiro Kawaoka +35 more
Reads0
Chats0
TLDR
It is found that SARS-CoV-2 isolates replicate efficiently in the lungs of Syrian hamsters and cause severe pathological lesions in the lung of these animals similar to commonly reported imaging features of COVID-19 patients with pneumonia.Abstract:
At the end of 2019, a novel coronavirus (severe acute respiratory syndrome coronavirus 2; SARS-CoV-2) was detected in Wuhan, China, that spread rapidly around the world, with severe consequences for human health and the global economy Here, we assessed the replicative ability and pathogenesis of SARS-CoV-2 isolates in Syrian hamsters SARS-CoV-2 isolates replicated efficiently in the lungs of hamsters, causing severe pathological lung lesions following intranasal infection In addition, microcomputed tomographic imaging revealed severe lung injury that shared characteristics with SARS-CoV-2-infected human lung, including severe, bilateral, peripherally distributed, multilobular ground glass opacity, and regions of lung consolidation SARS-CoV-2-infected hamsters mounted neutralizing antibody responses and were protected against subsequent rechallenge with SARS-CoV-2 Moreover, passive transfer of convalescent serum to naive hamsters efficiently suppressed the replication of the virus in the lungs even when the serum was administrated 2 d postinfection of the serum-treated hamsters Collectively, these findings demonstrate that this Syrian hamster model will be useful for understanding SARS-CoV-2 pathogenesis and testing vaccines and antiviral drugsread more
Citations
More filters
Posted ContentDOI
Synthetic Multiantigen MVA Vaccine COH04S1 Protects Against SARS-CoV-2 in Syrian Hamsters and Non-Human Primates
Flavia Chiuppesi,Vu H. Nguyen,Yoonsuh Park,Heidi Contreras,Veronica Karpinski,Katelyn Faircloth,Jenny Nguyen,Mindy Kha,Daisy Johnson,Joy Martinez,Angelina Iniguez,Qiao Zhou,Teodora Kaltcheva,Paul Frankel,Swagata Kar,Ankur Sharma,Hanne Leth Andersen,Mark G. Lewis,Yuriy Shostak,Felix Wussow,Don J. Diamond +20 more
TL;DR: In this article, a synthetic multiantigen Modified Vaccinia Ankara-based SARS-CoV-2 vaccine that co-expresses spike and nucleocapsid antigens was developed.
Journal ArticleDOI
Hyper-Immune Bovine Milk as an Immunological and Nutritional Supplement for COVID-19
TL;DR: In this paper , an isolated dairy farm was established, and nine mixed Holstein X Simmental dairy cattle in their 6-7 months of gestation period were chosen for hyper-immunization with inactivated Severe acute respiratory syndrome corona virus-2 (SARS-CoV-2), six cows were inoculated with 2 ml of 109.4/ml (TCID50) of the virus.
Journal ArticleDOI
A Live Attenuated COVID-19 Candidate Vaccine for Children: Protection against SARS-CoV-2 Challenge in Hamsters
Rajeev Mehla,Prasad Kokate,Sarika R. Bhosale,Vivek Vaidya,V. Narayanan,Radha Shandil,Mayas Singh,G.R. Rudramurthy,Chakenahalli N. Naveenkumar,Kumaraswamy Bharathkumar,Rob Coleman,Steffen Mueller,Rajeev M. Dhere,Leena Yeolekar +13 more
TL;DR: Li et al. as discussed by the authors developed a live attenuated COVID-19 vaccine with an aim to vaccinate children beyond 6 months of age, and tested the vaccine candidate on hamsters, which showed high levels of neutralizing antibodies and exhibited complete protection against SARS-CoV-2 wild-type isolates.
Journal ArticleDOI
Development of a Syrian hamster anti-PD-L1 monoclonal antibody enables oncolytic adenoviral immunotherapy modelling in an immunocompetent virus replication permissive setting
James H.A. Clubb,Tatiana V. Kudling,Mykhailo Girych,L. Haybout,S. Pakola,Firas Hamdan,Victor Cervera-Carrascon,Annabrita Hemmes,Susanna Grönberg-Vähä-Koskela,Joao Manuel Santos,Dafne Carolina Alves Quixabeira,Saru Basnet,Camilla Heiniö,Victor H. Arias,Elise Jirovec,Shreyas S. Kaptan,Riikka Havunen,Suvi Sorsa,A. Erikat,Joel Schwartz,Marjukka Anttila,Katri Aro,Tapani Viitala,Ilpo Vattulainen,Vincenzo Cerullo,Anna Kanerva,Akseli Hemminki +26 more
TL;DR: In this article , an anti-Syrian hamster anti-PD-L1 mAb was developed to enable the evaluation of safety and efficacy, when combined with an oncolytic adenovirus encoding tumour necrosis factor alpha and interleukin-2 (IL-2) (Ad5/3-E2F-D24-hTNFα-IRES-hIL-1 or TILT-123).
Journal ArticleDOI
Intranasal vaccination of hamsters with a Newcastle disease virus vector expressing the S1 subunit protects animals against SARS-CoV-2 disease
M. Fernández Díaz,Katherine Calderón,Aldo Rojas-Neyra,Vikram N. Vakharia,Ricardo Choque-Guevara,A. Montalvan-Avalos,Astrid Poma-Acevedo,Dora Rios-Matos,Andres Agurto-Arteaga,Maria de Grecia Cauti-Mendoza,Norma Perez-Martinez,Gisela Isasi-Rivas,Luis Tataje-Lavanda,Yacory Sernaque-Aguilar,Freddy Ygnacio,Manuel Criollo-Orozco,Edison Huaccachi-Gonzalez,Elmer Delgado-Ccancce,D. Villanueva-Perez,Ricardo Montesinos-Millan,Kristel Gutierrez-Manchay,Katherinne Pauyac-Antezana,I. Ramírez-Ortiz,Stefany Quiñones-Garcia,Yudith Cauna-Orocollo,Katherine Vallejos-Sánchez,Angela A. Rios-Angulo,Dennis Núñez-Fernández,Mario I. Salguedo-Bohorquez,Julio Ticona,Manolo Fernández-Sánchez,Eliana Icochea,Luis Guevara-Sarmiento,Ricardo Antiparra,Manuel Ardiles-Reyes,Naer Chipana-Flores,Xiomara Chunga-Girón,L. De La Cruz,Nicolás E. Delgado-Pease,Christian Elugo-Guevara,Manolo Fernández-Díaz,Manolo Sánchez,Oscar Heredia-Almeyda,Edison Huaccachi Gonzalez,Pedro Huerta-Roque,Gabriel Jiménez-Avalos,Romina A. Juscamaita-Bartra,Abraham Licla-Inca,Adiana Ochoa-Ortiz,Gustavo E. Olivos-Ramirez,Erika Páucar-Montoro,Jose L. Perez-Martinez,Daniel Ramos-Sono,Yomara K. Romero,Patricia Sheen,Luis F. Soto,A. P. Vargas-Ruiz,Renzo G. Villena,Mirko Zimic +58 more
TL;DR: In this paper , the authors developed three recombinant Newcastle disease virus (rNDV) vectored vaccines and assessed their immunogenicity, safety, and protective efficacy against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in mice and hamsters.
References
More filters
Journal ArticleDOI
Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China
Chaolin Huang,Yeming Wang,Xingwang Li,Lili Ren,Jianping Zhao,Yi Hu,Li Zhang,Guohui Fan,Jiuyang Xu,Xiaoying Gu,Zhenshun Cheng,Ting Yu,Jia'an Xia,Yuan Wei,Wenjuan Wu,Xuelei Xie,Wen Yin,Li Hui,Min Liu,Yan Xiao,Hong Gao,Li Guo,Jungang Xie,Guang-Fa Wang,Rongmeng Jiang,Zhancheng Gao,Qi Jin,Jianwei Wang,Bin Cao +28 more
TL;DR: The epidemiological, clinical, laboratory, and radiological characteristics and treatment and clinical outcomes of patients with laboratory-confirmed 2019-nCoV infection in Wuhan, China, were reported.
Journal ArticleDOI
A Novel Coronavirus from Patients with Pneumonia in China, 2019.
Na Zhu,Dingyu Zhang,Wenling Wang,Xingwang Li,Bo Yang,Jingdong Song,Xiang Zhao,Baoying Huang,Weifeng Shi,Roujian Lu,Peihua Niu,Faxian Zhan,Xuejun Ma,Dayan Wang,Wenbo Xu,Wenbo Xu,Guizhen Wu,George F. Gao,Wenjie Tan +18 more
TL;DR: Human airway epithelial cells were used to isolate a novel coronavirus, named 2019-nCoV, which formed a clade within the subgenus sarbecovirus, Orthocoronavirinae subfamily, which is the seventh member of the family of coronaviruses that infect humans.
Journal ArticleDOI
A pneumonia outbreak associated with a new coronavirus of probable bat origin
Peng Zhou,Xing-Lou Yang,Xian Guang Wang,Ben Hu,Lei Zhang,Wei Zhang,Hao Rui Si,Yan Zhu,Bei Li,Chao Lin Huang,Hui-Dong Chen,Jing Chen,Yun Luo,Hua Guo,Ren Di Jiang,Meiqin Liu,Ying Chen,Xu Rui Shen,Xi Wang,Xiao Shuang Zheng,Kai Zhao,Quanjiao Chen,Fei Deng,Lin Lin Liu,Bing Yan,Fa Xian Zhan,Yan-Yi Wang,Gengfu Xiao,Zhengli Shi +28 more
TL;DR: Identification and characterization of a new coronavirus (2019-nCoV), which caused an epidemic of acute respiratory syndrome in humans in Wuhan, China, and it is shown that this virus belongs to the species of SARSr-CoV, indicates that the virus is related to a bat coronav virus.
Journal ArticleDOI
SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor
Markus Hoffmann,Hannah Kleine-Weber,Simon Schroeder,Nadine Krüger,Tanja Herrler,Sandra Erichsen,Tobias S. Schiergens,Georg Herrler,Nai Huei Wu,Andreas Nitsche,Marcel A. Müller,Christian Drosten,Christian Drosten,Stefan Pöhlmann +13 more
TL;DR: It is demonstrated that SARS-CoV-2 uses the SARS -CoV receptor ACE2 for entry and the serine protease TMPRSS2 for S protein priming, and it is shown that the sera from convalescent SARS patients cross-neutralized Sars-2-S-driven entry.
Journal ArticleDOI
Presenting Characteristics, Comorbidities, and Outcomes Among 5700 Patients Hospitalized With COVID-19 in the New York City Area.
Safiya Richardson,Safiya Richardson,Jamie S. Hirsch,Jamie S. Hirsch,Mangala Narasimhan,James M. Crawford,Thomas McGinn,Thomas McGinn,Karina W. Davidson,Karina W. Davidson,Douglas P. Barnaby,Douglas P. Barnaby,Lance B Becker,John Chelico,John Chelico,Stuart L. Cohen,Stuart L. Cohen,Jennifer Cookingham,Kevin Coppa,Michael A Diefenbach,Andrew J. Dominello,Joan Duer-Hefele,Louise Falzon,Jordan Gitlin,Negin Hajizadeh,Negin Hajizadeh,Tiffany G. Harvin,David Hirschwerk,Eun Ji Kim,Eun Ji Kim,Zachary Kozel,Lyndonna Marrast,Lyndonna Marrast,Jazmin N. Mogavero,Gabrielle A. Osorio,Michael Qiu,Theodoros P. Zanos +36 more
TL;DR: This case series provides characteristics and early outcomes of sequentially hospitalized patients with confirmed COVID-19 in the New York City area and assesses outcomes during hospitalization, such as invasive mechanical ventilation, kidney replacement therapy, and death.
Related Papers (5)
A pneumonia outbreak associated with a new coronavirus of probable bat origin
Peng Zhou,Xing-Lou Yang,Xian Guang Wang,Ben Hu,Lei Zhang,Wei Zhang,Hao Rui Si,Yan Zhu,Bei Li,Chao Lin Huang,Hui-Dong Chen,Jing Chen,Yun Luo,Hua Guo,Ren Di Jiang,Meiqin Liu,Ying Chen,Xu Rui Shen,Xi Wang,Xiao Shuang Zheng,Kai Zhao,Quanjiao Chen,Fei Deng,Lin Lin Liu,Bing Yan,Fa Xian Zhan,Yan-Yi Wang,Gengfu Xiao,Zhengli Shi +28 more
Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China
Chaolin Huang,Yeming Wang,Xingwang Li,Lili Ren,Jianping Zhao,Yi Hu,Li Zhang,Guohui Fan,Jiuyang Xu,Xiaoying Gu,Zhenshun Cheng,Ting Yu,Jia'an Xia,Yuan Wei,Wenjuan Wu,Xuelei Xie,Wen Yin,Li Hui,Min Liu,Yan Xiao,Hong Gao,Li Guo,Jungang Xie,Guang-Fa Wang,Rongmeng Jiang,Zhancheng Gao,Qi Jin,Jianwei Wang,Bin Cao +28 more